CN114246821B - Moisturizing eye cream and preparation method thereof - Google Patents

Moisturizing eye cream and preparation method thereof Download PDF

Info

Publication number
CN114246821B
CN114246821B CN202210025876.6A CN202210025876A CN114246821B CN 114246821 B CN114246821 B CN 114246821B CN 202210025876 A CN202210025876 A CN 202210025876A CN 114246821 B CN114246821 B CN 114246821B
Authority
CN
China
Prior art keywords
percent
component
eye cream
extract
moisturizing eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210025876.6A
Other languages
Chinese (zh)
Other versions
CN114246821A (en
Inventor
张晖
胡秀
李永泉
薛彬娥
郭微
廖柏勇
代文魁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhongkai University of Agriculture and Engineering
Original Assignee
Zhongkai University of Agriculture and Engineering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongkai University of Agriculture and Engineering filed Critical Zhongkai University of Agriculture and Engineering
Priority to CN202210025876.6A priority Critical patent/CN114246821B/en
Publication of CN114246821A publication Critical patent/CN114246821A/en
Application granted granted Critical
Publication of CN114246821B publication Critical patent/CN114246821B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a moisturizing eye cream and a preparation method thereof. The ginger root oil, the bisabolol, the hyaluronic acid, the water-soluble ceramide, the ginger root extract and other plant extracts are added into the moisturizing eye cream, and the prepared moisturizing eye cream can effectively moisturize the skin around eyes, improve the glossiness, is pleasant in smell, and has good use experience and high skin comfort level.

Description

Moisturizing eye cream and preparation method thereof
Technical Field
The invention relates to the technical field of cosmetics, in particular to moisturizing eye cream and a preparation method thereof.
Background
With age, facial skin ages gradually, and eye skin problems are more prominent. In order to delay the aging of skin around eyes, besides ensuring sufficient sleep and developing good living habits and eye habits in daily life, a common method is to use moisturizing eye cosmetics, and eye cream is the most common eye cosmetics.
Disclosure of Invention
The invention aims at overcoming the defects and shortcomings of the prior art and providing the moisturizing eye cream.
Another object of the present invention is to provide a method for preparing the above moisturizing eye cream.
The aim of the invention is achieved by the following technical scheme: the moisturizing eye cream comprises the following components in percentage by mass: and A1: hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer 0.6-1.4%, glycerin 3-6% and water balance; and A2: 0.6 to 1.2 percent of butanediol and 0.1 to 0.5 percent of hyaluronic acid; and A3: inositol 1.5% -2.5%; and the component B comprises the following components: 0.5 to 1 percent of behenyl alcohol, 1 to 1.4 percent of cetostearyl alcohol, 0.3 to 0.4 percent of stearic acid, 1.8 to 2.2 percent of cetostearyl alcohol, 0.8 to 1.3 percent of trilaurin, 1.9 to 2.3 percent of coco-caprylate, 1.8 to 2.2 percent of polydimethylsiloxane, 1.5 to 1.8 percent of plant squalane, 0.05 to 0.4 percent of ginger root oil, 0.6 to 0.8 percent of white pool seed oil, 1.0 to 1.2 percent of isononyl isononanoate, 0.3 to 0.6 percent of vitamin E, 0.05 to 0.5 percent of bisabolol, 0.05 to 0.5 percent of ginger root extract and 0.4 to 0.5 percent of mango seed fat; and C, component: 0.4 to 0.5 percent of p-hydroxyacetophenone, 2 to 3 percent of butanediol, 0.1 to 0.15 percent of ethylhexyl glycerol and 0.4 to 0.5 percent of 1, 2-hexanediol; and D, a component: 0.4% -0.5% of Vc ethyl ether; and E component: 2.5 to 3 percent of plant extract mixture and 0.1 to 0.3 percent of water-soluble ceramide.
Preferably, the moisturizing eye cream comprises the following components in percentage by mass: and A1: hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer 0.9-1.2%, glycerin 4-5% and water balance; and A2: 0.6 to 1 percent of butanediol and 0.1 to 0.4 percent of hyaluronic acid; and A3: inositol 1.5% -2%; and the component B comprises the following components: 0.6 to 0.7 percent of behenyl alcohol, 1.1 to 1.2 percent of cetostearyl alcohol, 0.3 percent of stearic acid, 1.9 to 2 percent of cetostearyl alcohol, 1.0 to 1.2 percent of trilaurin, 2 percent of cocoyl alcohol-caprylate, 2 percent of polydimethylsiloxane, 1.5 percent of plant squalane, 0.1 to 0.3 percent of ginger root oil, 0.8 percent of white pool flower seed oil, 1.2 percent of isononyl isononanoate, 0.4 to 0.5 percent of vitamin E, 0.2 to 0.4 percent of bisabolol, 0.1 to 0.35 percent of ginger root extract and 0.5 percent of mango seed fat; and C, component: 0.5% of p-hydroxyacetophenone, 3% of butanediol, 0.1% of ethylhexyl glycerol and 0.5% of 1, 2-hexanediol; and D, a component: 0.4% -0.5% of Vc ethyl ether; and E component: 3% of plant extract mixture and 0.3% of water-soluble ceramide.
The plant extract mixture comprises the following components in percentage by mass: 0.01% -10% of capsicum frutescens extract, 0.05% -10% of ruscus aculeatus root extract, 0.1% -20% of grapefruit extract, 0.01% -3.0% of sodium benzoate, 0.05% -3.0% of aminoethylphosphinic acid, 0.1% -10% of Equisetum arvense extract, 0.01% -5.0% of Glycyrrhiza glabra root extract and the balance of water.
The preparation method of the moisturizing eye cream comprises the following steps:
(1) Uniformly mixing the A1 component and the A2 component which are respectively and previously dispersed, and uniformly mixing the A3 component;
(2) Dispersing the component B at 90-95 ℃ for 10min, mixing with the product obtained in the step (1), homogenizing, cooling to 70 ℃, adding the component C which is dispersed in advance at 80 ℃, and uniformly mixing;
(3) Mixing the component D with the product obtained in the step (2) at 45-50 ℃, uniformly dispersing, adding the component E, and completely dissolving to obtain the moisturizing eye cream.
The A1 component in the step (1) is uniformly dispersed in advance by heating at the speed of between 3000 and 3500rpm and at the temperature of between 95 and 90 ℃ for 15 to 20 minutes.
The step (1) is characterized in that the mixing is carried out for 15-20min.
The homogenization in the step (2) is 3000-3500rpm for 15-20min.
And (3) uniformly dispersing in the step (3) for 15-20min.
The dissolution in the step (3) is completely stirring for 15-20min.
Compared with the prior art, the invention has the following beneficial effects:
the moisturizing eye cream disclosed by the invention contains ginger root oil, bisabolol, hyaluronic acid, water-soluble ceramide, ginger root extract and other plant extracts, can effectively moisturize the skin around eyes, improves the glossiness, is pleasant in smell, and is good in use experience and high in skin comfort level.
Detailed Description
The following description of the technical solutions in the embodiments of the present invention will be clear and complete, and it is obvious that the described embodiments are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Examples 1 to 4
The formulation of the moisturizing eye cream in each example is shown in table 1, and the preparation method comprises the following steps:
1. adding hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer and glycerin into water, homogenizing at 3000rpm, adding into a main pot, heating to 95deg.C, maintaining the temperature for 20min, stirring, and dispersing uniformly;
2. stirring and dispersing butanediol and hyaluronic acid components uniformly, then putting into a main pot, stirring for 20 minutes, and completely dissolving;
3. the inositol is put into a main pot and stirred for 15 minutes;
4. adding behenyl alcohol, cetostearyl alcohol, stearic acid, cetostearyl alcohol, trilaurin, cocoyl alcohol-caprylate, polydimethylsiloxane, plant squalane, ginger root oil, white pond flower seed oil, isononyl isononanoate, vitamin E, bisabolol, ginger root extract and mango seed fat into an oil phase pot, heating to 90 ℃, preserving heat and stirring for 10 minutes, pumping into a main pot, homogenizing for 15 minutes at 3200rpm, and starting cooling water to cool to 70 ℃;
5. adding p-hydroxyacetophenone, butanediol, ethylhexyl glycerol and 1, 2-hexanediol which are uniformly dispersed at 80 ℃ in advance into a main pot, stirring for 15 minutes, and uniformly mixing;
6. cooling to 45 ℃, adding Vc ethyl ether into a main pot, mixing and stirring for 15 minutes, and uniformly;
7. pre-preparing plant extract mixture (1% of semen Setariae pepper fruit extract, 2% of false leaf tree root extract, 5% of grapefruit fruit extract, 2% of sodium benzoate, 3% of aminoethylphosphinic acid, 4% of herba Equiseti Arvinsis extract, 2% of Glycyrrhiza glabra root extract, and the balance of water), adding into main pot, adding water-soluble ceramide, mixing, stirring for 20min, and dissolving completely;
8. cooling to 35 ℃, inspecting the semi-finished product, and discharging after the inspection is qualified. The test items and criteria are shown in Table 2.
TABLE 1
Figure BDA0003464613280000031
Figure BDA0003464613280000041
TABLE 2
Figure BDA0003464613280000042
Figure BDA0003464613280000051
Comparative examples 1 to 4
The moisturizing eye creams of comparative examples 1 to 4 differ from example 1 only in the formulation, and the formulation of the moisturizing eye creams in each comparative example is shown in table 3.
TABLE 3 Table 3
Figure BDA0003464613280000052
/>
Figure BDA0003464613280000061
Effect detection
1. Moisture effect test
To verify the efficacy of the eye cream of the present invention, the samples obtained in examples 1 to 4 and comparative examples 1 to 4 were subjected to a moisturizing effect test.
The testing method comprises the following steps:
the group of 25-45 years old volunteers was selected, and the volunteers were patients without serious systemic disease, immunodeficiency or autoimmune disease, patients without active allergic disease, patients without serious allergic history to cosmetics, patients without hormone drugs and immunosuppressants in the past month, and subjects without other clinical testers. Volunteers were divided into 8 groups of 10 persons each, with no significant differences between the groups. Skin around eyes is selected as a test part, the skin is tested once before the test (i.e. the product of the invention and the comparative example is not used), the tested product is used after the face is cleaned in the morning and evening every day, the time of applying the sample is counted, and the moisture content of the horny layer and the skin glossiness of the test area are measured in 28 days. The test products were the samples of examples 1-4 and comparative examples 1-4, respectively. The stratum corneum moisture content and Skin gloss were measured using a Skin moisture test probe Cornometer CM825 and a Skin gloss test probe Skin-Glossymeter GL200 (Courage+Khazaka, 50829Koln, germany), respectively.
Analysis of the result data:
a. calculation of moisture and gloss Change amount
The average difference between the moisture content of the stratum corneum and the skin glossiness of the tested part before and after the product is obtained by subtracting the measured value of the tested part before the use from the measured value of the tested part after the sample, and the calculation formulas are as shown in the following formulas (1) and (2).
(1)T=(M x -M o )/10;(2)G=(N x -N o ) 10; wherein: t is skin moisture variation; m is M x A measurement of skin moisture 28 days after use of the product; m is M o Pre-use measurements for skin moisture products; g is the skin glossiness variation; n (N) x To measure skin gloss 28 days after use of the product; n (N) o Is a measurement of skin gloss product before use.
The test results are shown in Table 4.
TABLE 4 Table 4
Sample numbering Average difference in skin moisture content Average difference in skin gloss
Example 1 34.00 3.36
Example 2 30.00 3.23
Example 3 29.00 3.18
Example 4 28.00 3.05
Comparative example 1 23.00 2.43
Comparative example 2 25.00 3.07
Comparative example 3 24.00 2.17
Comparative example 4 25.00 3.02
From the test results in Table 4, it is evident that the products obtained in examples 1-4 have a significant improvement in moisture content and gloss of the skin of the user, wherein the products obtained in examples 1-2 are improved to a higher degree than the products obtained in examples 3 and 4. From the test results of the products obtained in comparative examples 1-4, it is known that the addition amount of the components in the eye cream formula has a great influence on the moisturizing effect of the products, especially when the addition amounts of ginger root oil, ginger root extract, hyaluronic acid and plant extract mixture are insufficient, the obtained products have obvious differences in skin moisture content and glossiness improving effect after use compared with the products of examples.
2. User experience testing
To test the use experience of the eye cream of the present invention, 8 samples of examples 1 to 4 and comparative examples 1 to 4 were subjected to a user experience test, and volunteers tested for moisturizing effect were subjected to a return visit investigation, and statistics were made as to whether the volunteers were dry after use and developed a white dust phenomenon, odor evaluation, and skin comfort evaluation. Wherein the odor evaluation total score is 5 points, and the 5 scoring criteria are: the smell is coordinated and natural, and pleasant aroma is obtained; the 4 scoring criteria were: the smell is coordinated, and a certain fragrance exists; the 3 scoring criteria are: the smell is general, has a certain special smell, but is generally coordinated and not objectionable; 2 scoring criteria: has certain unpleasant smell, weaker coordination and general adaptation after habit; score 1 criteria: the dissonance and peculiar smell are obvious, objectionable and cannot be adapted. The total score was rated 5 points using skin comfort, with 5 scoring criteria: the texture is comfortable when the skin-care product is used, and the skin can absorb quickly after the skin-care product is used; the 4 scoring criteria were: the texture is good when in use, and the skin can absorb quickly after use; the 3 scoring criteria are: the texture is general when in use, and the skin absorption speed is general after use (the whole is the same as that of the commercial eye cream); the scoring criteria for 2 were: the texture is poor (not fine or smooth) when in use, or the absorption speed is slower after use; the scoring criteria for 1 were: the texture is poor when in use, and the skin absorption speed is low after use. The scores were counted and averaged, and the results are shown in Table 5.
TABLE 5
Figure BDA0003464613280000081
As can be seen from the table, the eye cream samples prepared in examples 1-4 were pleasant in overall smell, and were good in skin comfort after use, and did not develop a phenomenon of dry and flaking.
In combination, the samples obtained in examples 1-4 have a good use experience and excellent skin quality enhancement, with the product obtained in example 1 being the most effective.
While the foregoing is directed to the preferred embodiments of the present invention, it will be appreciated by those skilled in the art that changes and modifications may be made without departing from the principles of the invention, such changes and modifications are also intended to be within the scope of the invention.

Claims (6)

1. The moisturizing eye cream is characterized by comprising the following components in percentage by mass: and A1: hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer 0.6-1.4%, glycerin 3-6% and water balance; and A2: 0.6 to 1.2 percent of butanediol and 0.1 to 0.5 percent of hyaluronic acid; and A3: inositol 1.5% -2.5%; and the component B comprises the following components: 0.5 to 1 percent of behenyl alcohol, 1 to 1.4 percent of cetostearyl alcohol, 0.3 to 0.4 percent of stearic acid, 1.8 to 2.2 percent of cetostearyl alcohol, 0.8 to 1.3 percent of trilaurin, 1.9 to 2.3 percent of coco-caprylate, 1.8 to 2.2 percent of polydimethylsiloxane, 1.5 to 1.8 percent of plant squalane, 0.05 to 0.4 percent of ginger root oil, 0.6 to 0.8 percent of white pool seed oil, 1.0 to 1.2 percent of isononyl isononanoate, 0.3 to 0.6 percent of vitamin E, 0.05 to 0.5 percent of bisabolol, 0.05 to 0.5 percent of ginger root extract and 0.4 to 0.5 percent of mango seed fat; and C, component: 0.4 to 0.5 percent of p-hydroxyacetophenone, 2 to 3 percent of butanediol, 0.1 to 0.15 percent of ethylhexyl glycerol and 0.4 to 0.5 percent of 1, 2-hexanediol; and D, a component: 0.4% -0.5% of Vc ethyl ether; and E component: 2.5 to 3 percent of plant extract mixture and 0.1 to 0.3 percent of water-soluble ceramide;
the plant extract mixture comprises the following components in percentage by mass: 0.01% -10% of capsicum frutescens extract, 0.05% -10% of ruscus aculeatus root extract, 0.1% -20% of grapefruit extract, 0.01% -3.0% of sodium benzoate, 0.05% -3.0% of aminoethylphosphinic acid, 0.1% -10% of Equisetum arvense extract and 0.01% -5.0% of Glycyrrhiza glabra root extract.
2. The moisturizing eye cream of claim 1, comprising the following components in percentage by mass: and A1: hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer 0.9-1.2%, glycerin 4-5% and water balance; and A2: 0.6 to 1 percent of butanediol and 0.1 to 0.4 percent of hyaluronic acid; and A3: inositol 1.5% -2%; and the component B comprises the following components: 0.6 to 0.7 percent of behenyl alcohol, 1.1 to 1.2 percent of cetostearyl alcohol, 0.3 percent of stearic acid, 1.9 to 2 percent of cetostearyl alcohol, 1.0 to 1.2 percent of trilaurin, 2 percent of cocoyl alcohol-caprylate, 2 percent of polydimethylsiloxane, 1.5 percent of plant squalane, 0.1 to 0.3 percent of ginger root oil, 0.8 percent of white pool flower seed oil, 1.2 percent of isononyl isononanoate, 0.4 to 0.5 percent of vitamin E, 0.2 to 0.4 percent of bisabolol, 0.1 to 0.35 percent of ginger root extract and 0.5 percent of mango seed fat; and C, component: 0.5% of p-hydroxyacetophenone, 3% of butanediol, 0.1% of ethylhexyl glycerol and 0.5% of 1, 2-hexanediol; and D, a component: 0.4% -0.5% of Vc ethyl ether; and E component: 3% of plant extract mixture and 0.3% of water-soluble ceramide.
3. A method of preparing a moisturizing eye cream according to any one of claims 1-2, comprising the steps of:
(1) Uniformly mixing the A1 component and the A2 component which are respectively and previously dispersed, and uniformly mixing the A3 component;
(2) Dispersing the component B at 90-95 ℃ for 10min, mixing with the product obtained in the step (1), homogenizing, cooling to 70 ℃, adding the component C which is dispersed in advance at 80 ℃, and uniformly mixing;
(3) Mixing the component D with the product obtained in the step (2) at 45-50 ℃, uniformly dispersing, adding the component E, and completely dissolving to obtain the moisturizing eye cream.
4. The method for preparing the moisturizing eye cream according to claim 3,
the A1 component in the step (1) is uniformly dispersed in advance by heating at the speed of between 3000 and 3500rpm and at the temperature of between 95 and 90 ℃ for 15 to 20 minutes;
the step (1) is characterized in that the mixing is carried out for 15-20min.
5. The method for preparing the moisturizing eye cream according to claim 3,
the homogenization in the step (2) is 3000-3500rpm for 15-20min.
6. The method for preparing the moisturizing eye cream according to claim 3,
the uniform dispersion in the step (3) is stirring for 15-20min;
the dissolution in the step (3) is completely stirring for 15-20min.
CN202210025876.6A 2022-01-11 2022-01-11 Moisturizing eye cream and preparation method thereof Active CN114246821B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210025876.6A CN114246821B (en) 2022-01-11 2022-01-11 Moisturizing eye cream and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210025876.6A CN114246821B (en) 2022-01-11 2022-01-11 Moisturizing eye cream and preparation method thereof

Publications (2)

Publication Number Publication Date
CN114246821A CN114246821A (en) 2022-03-29
CN114246821B true CN114246821B (en) 2023-05-23

Family

ID=80796381

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210025876.6A Active CN114246821B (en) 2022-01-11 2022-01-11 Moisturizing eye cream and preparation method thereof

Country Status (1)

Country Link
CN (1) CN114246821B (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104739723A (en) * 2015-03-19 2015-07-01 广东轻工职业技术学院 Tightening eye cream
CN109010189A (en) * 2018-09-30 2018-12-18 长春中医药大学 A kind of anti-oxidation function eye cream and preparation method thereof adding ginseng lipoid plastid
CN109200008A (en) * 2018-08-29 2019-01-15 华妍堂(北京)生物科技有限责任公司 A kind of eye cream and preparation method thereof
CN109330948A (en) * 2018-12-05 2019-02-15 福建片仔癀化妆品有限公司 A kind of compact eye cream and preparation method thereof
CN109662925A (en) * 2019-01-22 2019-04-23 广州达人研选生物科技有限公司 A kind of safe and non-stimulating eye cream and preparation method thereof
CN112315882A (en) * 2020-11-23 2021-02-05 山东福瑞达生物工程有限公司 Soothing, repairing and moisturizing cream and preparation method thereof
CN113648272A (en) * 2021-08-26 2021-11-16 华侨大学 Moisturizing and wrinkle-removing eye cream and preparation method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104739723A (en) * 2015-03-19 2015-07-01 广东轻工职业技术学院 Tightening eye cream
CN109200008A (en) * 2018-08-29 2019-01-15 华妍堂(北京)生物科技有限责任公司 A kind of eye cream and preparation method thereof
CN109010189A (en) * 2018-09-30 2018-12-18 长春中医药大学 A kind of anti-oxidation function eye cream and preparation method thereof adding ginseng lipoid plastid
CN109330948A (en) * 2018-12-05 2019-02-15 福建片仔癀化妆品有限公司 A kind of compact eye cream and preparation method thereof
CN109662925A (en) * 2019-01-22 2019-04-23 广州达人研选生物科技有限公司 A kind of safe and non-stimulating eye cream and preparation method thereof
CN112315882A (en) * 2020-11-23 2021-02-05 山东福瑞达生物工程有限公司 Soothing, repairing and moisturizing cream and preparation method thereof
CN113648272A (en) * 2021-08-26 2021-11-16 华侨大学 Moisturizing and wrinkle-removing eye cream and preparation method thereof

Also Published As

Publication number Publication date
CN114246821A (en) 2022-03-29

Similar Documents

Publication Publication Date Title
CN111603433B (en) Mild washing and protecting article for infants and preparation method thereof
CN108078833B (en) Slimming and fat reducing cream and preparation method thereof
CN106727020A (en) Baby's moistening skin-care frost
CN108524305B (en) Children skin barrier repair moisturizing cream and preparation method thereof
CN109674687B (en) Emulsified lipstick and preparation method thereof
CN108542870A (en) A kind of infant's face cream of mildly releiving
CN108403486A (en) A kind of repair cream and preparation method thereof
CN113057902A (en) Camellia seed oil cream containing hydrolyzed vegetable protein and preparation method thereof
CN111658555A (en) Nano anti-wrinkle essence cream and preparation method thereof
CN111700851B (en) Soothing and moisturizing composition and preparation method and application thereof
CN108392455A (en) Face cream and preparation method thereof containing dendrobium candidum extract
CN114246821B (en) Moisturizing eye cream and preparation method thereof
CN108852976A (en) A kind of brilliant profit nourishing breast
CN113041174A (en) Camellia seed oil essence containing hydrolyzed vegetable protein and preparation method and application thereof
CN116392403A (en) Sun-screening composition, oil-in-water sun-screening emulsion preparation, and preparation method and application thereof
CN109908071B (en) Milk skin care emulsion and preparation method thereof
CN114515261B (en) Male conditioning essence and preparation method thereof
CN115068389A (en) Multi-effect composition, essence cream and preparation method thereof
CN105640836B (en) A kind of surfactant and preparation method thereof containing lotus active constituent
CN113274339A (en) Silicone oil cream with itching relieving and moisture keeping effects and preparation method thereof
CN113057901A (en) Camellia seed oil skin care composition containing hydrolyzed vegetable protein and preparation method and application thereof
CN111888275A (en) Composition and preparation method and application thereof
Supriadi et al. Formulation and Evaluation of Grape Seed Oil (Vitis Vinifera, L) Facial Cream with Variations in The Concentration of Stearic Acid as an Emulsifier
CN117243832B (en) Essence with anti-wrinkle effect and preparation method thereof
CN115154355B (en) Collagen-rich composition, and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant